tirzepatide discontinuation (sold under the names Munjaro or Zepbound) leads to weight regain!!! As you can see in the image, the subgroup of participants who underwent the change from tirzepatide to placebo Tirzepatide for Obesity Treatment and

doi: 10.3945/ajcn.110.003483

#iHeardSTL #GLP1 #WeightLossDrugs

In addition, some nanoparticles enter cells by interacting with the cell membrane or fusing, which may cause nonspecific cytolysis and thus have cytotoxicity limitations

Loss of CD4 + T cell-intrinsic arginase 1 accelerates Th1 response kinetics and reduces lung pathology during influenza infection

While the first GLP-1 was approved by the FDA more than 20 years ago, to treat Type 2 diabetes, the use of these drugs took off in 2021 when Novo Nordisk received approval for a semaglutide drug to treat obesity, with the brand name Wegovy

At Infusion for Health, we strive to offer a premium experience at a reasonable price for all of our patients